JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M500866200 on March 3, 2005

J. Biol. Chem., Vol. 280, Issue 18, 17694-17700, May 6, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/18/17694    most recent
M500866200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kotoshiba, S.
Right arrow Articles by Nakayama, K. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kotoshiba, S.
Right arrow Articles by Nakayama, K. I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular Dissection of the Interaction between p27 and Kip1 Ubiquitylation-promoting Complex, the Ubiquitin Ligase That Regulates Proteolysis of p27 in G1 Phase*

Shuhei Kotoshiba{ddagger}§, Takumi Kamura{ddagger}§, Taichi Hara{ddagger}§, Noriko Ishida§, and Keiichi I. Nakayama{ddagger}§||

From the {ddagger}Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, §CREST, the Japan Science and Technology Corporation, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, and the Department of Developmental Biology, Center for Translational and Advanced Animal Research on Human Disease, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan

The cyclin-dependent kinase (CDK) inhibitor p27 is degraded at the G0-G1 transition of the cell cycle by the ubiquitin-proteasome pathway in a Skp2-independent manner. We recently identified a novel ubiquitin ligase, KPC (Kip1 ubiquitylation-promoting complex), consisting of KPC1 and KPC2, which regulates the ubiquitin-dependent degradation of p27 at G1 phase. We have now investigated the structural requirements for the interactions of KPC1 with KPC2 and p27. The NH2-terminal region of KPC1 was found to be responsible for binding to KPC2 and to p27. KPC1 mutants that lack this region failed to mediate polyubiquitylation of p27 in vitro and expression of one such mutant delayed p27 degradation in vivo. We also generated a series of deletion mutants of p27 and found that KPC failed to polyubiquitylate a p27 mutant that lacks the CDK inhibitory domain. Interestingly, the cyclin E·CDK2 complex prevented both the interaction of KPC with p27 as well as KPC-mediated polyubiquitylation of p27. A complex of cyclin E with a kinase-negative mutant of CDK2 also exhibited these inhibitory effects, suggesting that cyclin E·CDK2 competes with KPC1 for access to the CDK inhibitory domain of p27. These results suggest that free p27 is recognized by the NH2-terminal region of KPC1, which also associates with KPC2, and that p27 is then polyubiquitylated by the COOH-terminal RING-finger domain of KPC1.


Received for publication, January 24, 2005 , and in revised form, March 2, 2005.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed. Tel.: 81-92-642-6815; Fax: 81-92-642-6819; E-mail: nakayak1{at}bioreg.kyushu-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
F. Felicetti, M. C. Errico, L. Bottero, P. Segnalini, A. Stoppacciaro, M. Biffoni, N. Felli, G. Mattia, M. Petrini, M. P. Colombo, et al.
The Promyelocytic Leukemia Zinc Finger-MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms
Cancer Res., April 15, 2008; 68(8): 2745 - 2754.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Petrovic, R. H. Costa, L. F. Lau, P. Raychaudhuri, and A. L. Tyner
FoxM1 Regulates Growth Factor-induced Expression of Kinase-interacting Stathmin (KIS) to Promote Cell Cycle Progression
J. Biol. Chem., January 4, 2008; 283(1): 453 - 460.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Susaki, K. Nakayama, and K. I. Nakayama
Cyclin D2 Translocates p27 out of the Nucleus and Promotes Its Degradation at the G0-G1 Transition
Mol. Cell. Biol., July 1, 2007; 27(13): 4626 - 4640.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Lecanda, T. V. Parekh, P. Gama, K. Lin, V. Liarski, S. Uretsky, K. Mittal, and L. I. Gold
Transforming Growth Factor-{beta}, Estrogen, and Progesterone Converge on the Regulation of p27Kip1 in the Normal and Malignant Endometrium
Cancer Res., February 1, 2007; 67(3): 1007 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Kouvaraki, A. L. Korapati, G. Z. Rassidakis, L. Tian, Q. Zhang, P. Chiao, L. Ho, D. B. Evans, and F. X. Claret
Potential Role of Jun Activation Domain-Binding Protein 1 as a Negative Regulator of p27kip1 in Pancreatic Adenocarcinoma.
Cancer Res., September 1, 2006; 66(17): 8581 - 8589.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Halfter, M. Friedrich, A. Resch, M. Kullmann, F. Stogbauer, E. B. Ringelstein, and L. Hengst
Oncostatin M Induces Growth Arrest by Inhibition of Skp2, Cks1, and Cyclin A Expression and Induced p21 Expression.
Cancer Res., July 1, 2006; 66(13): 6530 - 6539.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Borriello, V. Cucciolla, M. Criscuolo, S. Indaco, A. Oliva, A. Giovane, D. Bencivenga, A. Iolascon, V. Zappia, and F. Della Ragione
Retinoic Acid Induces p27Kip1 Nuclear Accumulation by Modulating Its Phosphorylation.
Cancer Res., April 15, 2006; 66(8): 4240 - 4248.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
W. Q. Li, Q. Jiang, E. Aleem, P. Kaldis, A. R. Khaled, and S. K. Durum
IL-7 promotes T cell proliferation through destabilization of p27Kip1
J. Exp. Med., March 20, 2006; 203(3): 573 - 582.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Besson, M. Gurian-West, X. Chen, K. S. Kelly-Spratt, C. J. Kemp, and J. M. Roberts
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression
Genes & Dev., January 1, 2006; 20(1): 47 - 64.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Hara, T. Kamura, S. Kotoshiba, H. Takahashi, K. Fujiwara, I. Onoyama, M. Shirakawa, N. Mizushima, and K. I. Nakayama
Role of the UBL-UBA Protein KPC2 in Degradation of p27 at G1 Phase of the Cell Cycle
Mol. Cell. Biol., November 1, 2005; 25(21): 9292 - 9303.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.